Chemical Structure (Eryped 01)
Ery-ped Suspension
Product Images NDC 24338-130
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ery-ped (NDC 24338-130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals), these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (200 mg per 5 mL Bottle Label)
EryPed 200 is an oral suspension of erythromycin ethylsuccinate used to treat bacterial infections. The NDC code for this product is 24336-132-13. The directions recommend vigorously shaking the mixture before use and taking it for 10 to 20 minutes after mixing. It is produced by AborPharmaceuticals and comes in a dosage of 200 milligrams of erythromycin ethylsuccinate.*
Principal Display Panel (400 mg per 5 mL Bottle Label)
NDC 24338-130-13 is a package of EryPed 400, an oral suspension containing Erythromycin ethylsuccinate. When mixed, the oral suspension provides 400mg of Erythromycin per 5mL. The dosage can be adjusted without regard to meals, and the suspension is suitable for both adults and children. The package contains 100mL of the suspension. Instructions for mixing are provided.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
